Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cornelis F Vos

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|May 31, 2024
Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case studyCornelis F Vos, Wietske L Hemminga, Rob E Aarnoutse, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 26, 2023
[Prevention of delirium in the Intensive Care Unit]Cornelis F Vos, Irene J van Diem-Zaal, Monica Pop-Purceleanu, et al.
Substance Abuse|October 12, 2020
Successful treatment of severe, treatment resistant GHB withdrawal through thiopental-comaCornelis F Vos, Monica Pop-Purceleanu, Maarten J W van den Berg, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 26, 2023
[Consider (es)ketamine for treatment-resistant depression]Mike van Verseveld, Sven Stuiver, Cornelis F Vos, et al.
Journal of Psychiatric Research|April 9, 2022
Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic reviewSophie E Ter Hark, Cornelis F Vos, Rob E Aarnoutse, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 28, 2024
A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorderCornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Clinical Pharmacokinetics|May 25, 2025
Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard DosingCornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Brain, Behavior, & Immunity - Health|August 23, 2021
Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysisCornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
Journal of Clinical Psychopharmacology|November 6, 2023
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic DepressionCornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 23, 2025
A comparison between rTMS and antidepressant medication on depressive symptom clusters in treatment-resistant depressionIris Dalhuisen, Tom Biemans, Cornelis F Vos, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|May 31, 2024
Increasing the bioavailability of oral esketamine by a single dose of cobicistat: A case studyCornelis F Vos, Wietske L Hemminga, Rob E Aarnoutse, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 26, 2023
[Prevention of delirium in the Intensive Care Unit]Cornelis F Vos, Irene J van Diem-Zaal, Monica Pop-Purceleanu, et al.
Substance Abuse|October 12, 2020
Successful treatment of severe, treatment resistant GHB withdrawal through thiopental-comaCornelis F Vos, Monica Pop-Purceleanu, Maarten J W van den Berg, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 26, 2023
[Consider (es)ketamine for treatment-resistant depression]Mike van Verseveld, Sven Stuiver, Cornelis F Vos, et al.
Journal of Psychiatric Research|April 9, 2022
Biomarkers as predictors of treatment response to tricyclic antidepressants in major depressive disorder: A systematic reviewSophie E Ter Hark, Cornelis F Vos, Rob E Aarnoutse, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 28, 2024
A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorderCornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Clinical Pharmacokinetics|May 25, 2025
Optimizing Nortriptyline Dosing: A Comparison between Pharmacogenetics-Based, Phenotype-Based, and Standard DosingCornelis F Vos, Marieke J H Coenen, Sophie E Ter Hark, et al.
Brain, Behavior, & Immunity - Health|August 23, 2021
Association of the neutrophil to lymphocyte ratio and white blood cell count with response to pharmacotherapy in unipolar psychotic depression: An exploratory analysisCornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
Journal of Clinical Psychopharmacology|November 6, 2023
The Relationship of Early Sleep Improvement With Response to Pharmacotherapy in Unipolar Psychotic DepressionCornelis F Vos, Tom K Birkenhäger, Willem A Nolen, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 23, 2025
A comparison between rTMS and antidepressant medication on depressive symptom clusters in treatment-resistant depressionIris Dalhuisen, Tom Biemans, Cornelis F Vos, et al.
Pageof 2